Related Experiment Video
Updated: Jun 14, 2025
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Challenges and Advances in Interventional Cardiology for Coronary Artery Disease Management
Leslie Marisol Lugo-Gavidia1,2, Marco Antonio Alcocer-Gamba3,4,5, Araceli Martinez-Cervantes3,5
1Mexican Academic Consortium for Clinical Data Acquisition SC, Sinaloa 80230, Mexico.
Insights
Percutaneous coronary intervention (PCI) advances cardiology for coronary artery disease (CAD). This review covers current PCI strategies and technologies to overcome challenges like calcification and restenosis for better patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Percutaneous coronary intervention (PCI) is a major advancement in treating coronary artery disease (CAD).
- Despite improvements, challenges like calcification, bifurcation lesions, and stent restenosis persist, impacting PCI efficacy.
Purpose of the Study:
- To provide an overview of current knowledge on endovascular revascularization in CAD.
- To discuss relevant trials, therapeutic strategies, and emerging technologies for complex PCI scenarios.
Main Methods:
- Literature review of key trials and studies in endovascular revascularization for CAD.
- Analysis of current therapeutic strategies and technological advancements in PCI.
Main Results:
- PCI has transformed CAD management, but significant challenges remain.
- New technologies and refined strategies are being developed to address complex PCI cases.
- Optimizing PCI is crucial for improving prognosis in patients with CAD.
Conclusions:
- Endovascular revascularization remains a cornerstone in CAD management.
- Ongoing research and technological innovation are essential to overcome PCI limitations.
- Addressing specific challenges in PCI can significantly improve patient outcomes and prognosis.
Abstract:
The development of percutaneous coronary intervention (PCI) has been one of the greatest advances in cardiology and has changed clinical practice for patients with coronary artery disease (CAD). Despite continuous improvements in operators' experience, techniques, and the development of new-generation devices, significant challenges remain in improving the efficacy of PCI, including calcification, bifurcation, multivascular disease, stent restenosis, and stent thrombosis, among others. The present review aims to provide an overview of the current status of knowledge of endovascular revascularization in CAD, including relevant trials, therapeutic strategies, and new technologies addressing particular scenarios that can impact the prognosis of this vulnerable population.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System